Inflammation has long been portrayed as something inherently bad; a process that needs to be fought or suppressed. In popular ...

Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...

Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...

In nutrition science, certain vitamins and minerals don’t work in isolation, they complement, amplify, or balance each other’s functions within the body. These “nutrient synergies” are increasingly ...

KDIGO Guideline suggests treatment with Nefecon should be considered in the majority of patients at risk of progressive loss of kidney function ...

This correlates remarkably well with geological evidence from the Moon and Earth showing a declining bombardment rate over the past few billion years. The asteroid belt, is often considered to be a ...

Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...

Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational momentum was driven primarily by continued ...

An international study led by experts at the University of Sydney and the Universidad Europea in Spain has found that longer ...

Challenges in respiratory vaccine development include immune response elicitation, personalized data, and alternative delivery methods like oral or intranasal routes to improve compliance. Federal ...

Planned U.S. launch of Anaphylm™ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the ...